These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24963662)

  • 21. Protection against a malaria challenge by sporozoite inoculation.
    Roestenberg M; McCall M; Hopman J; Wiersma J; Luty AJ; van Gemert GJ; van de Vegte-Bolmer M; van Schaijk B; Teelen K; Arens T; Spaarman L; de Mast Q; Roeffen W; Snounou G; Rénia L; van der Ven A; Hermsen CC; Sauerwein R
    N Engl J Med; 2009 Jul; 361(5):468-77. PubMed ID: 19641203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental infection of the neotropical malaria vector Anopheles darlingi by human patient-derived Plasmodium vivax in the Peruvian Amazon.
    Bharti AR; Chuquiyauri R; Brouwer KC; Stancil J; Lin J; Llanos-Cuentas A; Vinetz JM
    Am J Trop Med Hyg; 2006 Oct; 75(4):610-6. PubMed ID: 17038681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of Plasmodium vivax sporogony in wild Anopheles stephensi in a malaria-endemic region of Western India.
    Balabaskaran Nina P; Mohanty AK; Ballav S; Vernekar S; Bhinge S; D'souza M; Walke J; Manoharan SK; Mascarenhas A; Gomes E; Chery L; Valecha N; Kumar A; Rathod PK
    Malar J; 2017 Jul; 16(1):284. PubMed ID: 28693607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya.
    Sherwood JA; Copeland RS; Taylor KA; Abok K; Oloo AJ; Were JB; Strickland GT; Gordon DM; Ballou WR; Bales JD; Wirtz RA; Wittes J; Gross M; Que JU; Cryz SJ; Oster CN; Roberts CR; Sadoff JC
    Vaccine; 1996 Jun; 14(8):817-27. PubMed ID: 8817830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are insecticide-treated bednets more protective against Plasmodium falciparum than Plasmodium vivax-infected mosquitoes?
    Bockarie MJ; Dagoro H
    Malar J; 2006 Feb; 5():15. PubMed ID: 16504027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using infective mosquitoes to challenge monkeys with Plasmodium knowlesi in malaria vaccine studies.
    Murphy JR; Weiss WR; Fryauff D; Dowler M; Savransky T; Stoyanov C; Muratova O; Lambert L; Orr-Gonzalez S; Zeleski KL; Hinderer J; Fay MP; Joshi G; Gwadz RW; Richie TL; Villasante EF; Richardson JH; Duffy PE; Chen J
    Malar J; 2014 Jun; 13():215. PubMed ID: 24893777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of the Panama strain of Plasmodium vivax for the testing of malarial vaccines in Aotus nancymai monkeys.
    Collins WE; Sullivan JS; Galland GG; Williams A; Nace D; Williams T
    Am J Trop Med Hyg; 2002 Nov; 67(5):454-8. PubMed ID: 12479543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.
    Leitner WW; Bergmann-Leitner ES; Angov E
    Malar J; 2010 May; 9():145. PubMed ID: 20507620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further studies on the sporozoite transmission of the Salvador I strain of Plasmodium vivax.
    Collins WE; Morris CL; Richardson BB; Sullivan JS; Galland GG
    J Parasitol; 1994 Aug; 80(4):512-7. PubMed ID: 8064516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine.
    Herrera S; Bonelo A; Perlaza BL; Fernández OL; Victoria L; Lenis AM; Soto L; Hurtado H; Acuña LM; Vélez JD; Palacios R; Chen-Mok M; Corradin G; Arévalo-Herrera M
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):3-9. PubMed ID: 16291760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous Supply of Plasmodium vivax Sporozoites from Colonized Anopheles darlingi in the Peruvian Amazon.
    Moreno M; Tong-Rios C; Orjuela-Sanchez P; Carrasco-Escobar G; Campo B; Gamboa D; Winzeler EA; Vinetz JM
    ACS Infect Dis; 2018 Apr; 4(4):541-548. PubMed ID: 29465219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competency of Anopheles stephensi mysorensis strain for Plasmodium vivax and the role of inhibitory carbohydrates to block its sporogonic cycle.
    Basseri HR; Doosti S; Akbarzadeh K; Nateghpour M; Whitten MM; Ladoni H
    Malar J; 2008 Jul; 7():131. PubMed ID: 18627630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observations on the biological nature of Plasmodium vivax sporozoites.
    Collins WE; Sullivan JS; Morris CL; Galland GG; Richardson BB
    J Parasitol; 1996 Apr; 82(2):216-9. PubMed ID: 8604086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction.
    Hermsen CC; de Vlas SJ; van Gemert GJ; Telgt DS; Verhage DF; Sauerwein RW
    Am J Trop Med Hyg; 2004 Aug; 71(2):196-201. PubMed ID: 15306710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi.
    Pinilla YT; C P Lopes S; S Sampaio V; Andrade FS; Melo GC; Orfanó AS; Secundino NFC; Guerra MGVB; Lacerda MVG; Kobylinski KC; Escobedo-Vargas KS; López-Sifuentes VM; Stoops CA; Baldeviano GC; Tarning J; Vasquez GM; Pimenta PFP; Monteiro WM
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006221. PubMed ID: 29444080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar trends of susceptibility in Anopheles arabiensis and Anopheles pharoensis to Plasmodium vivax infection in Ethiopia.
    Abduselam N; Zeynudin A; Berens-Riha N; Seyoum D; Pritsch M; Tibebu H; Eba K; Hoelscher M; Wieser A; Yewhalaw D
    Parasit Vectors; 2016 Oct; 9(1):552. PubMed ID: 27756355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium vivax: transmission-blocking immunity in a malaria-endemic area of Colombia.
    Arévalo-Herrera M; Solarte Y; Zamora F; Mendez F; Yasnot MF; Rocha L; Long C; Miller LH; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):38-43. PubMed ID: 16291765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Relative Contribution of Symptomatic and Asymptomatic Plasmodium vivax and Plasmodium falciparum Infections to the Infectious Reservoir in a Low-Endemic Setting in Ethiopia.
    Tadesse FG; Slater HC; Chali W; Teelen K; Lanke K; Belachew M; Menberu T; Shumie G; Shitaye G; Okell LC; Graumans W; van Gemert GJ; Kedir S; Tesfaye A; Belachew F; Abebe W; Mamo H; Sauerwein R; Balcha T; Aseffa A; Yewhalaw D; Gadisa E; Drakeley C; Bousema T
    Clin Infect Dis; 2018 Jun; 66(12):1883-1891. PubMed ID: 29304258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites.
    Swearingen KE; Lindner SE; Flannery EL; Vaughan AM; Morrison RD; Patrapuvich R; Koepfli C; Muller I; Jex A; Moritz RL; Kappe SHI; Sattabongkot J; Mikolajczak SA
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005791. PubMed ID: 28759593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the variability of incubation period of vivax malaria following mosquito biting].
    Li QJ; Tang LY; Pang LL; Zhang XJ; Wang ZM; He YZ; Huang Z; Yang BL; Wang WJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1989; 7(1):28-31. PubMed ID: 2670311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.